Microenvironment On Demand technology was invented by key innovators at the University of California, San Francisco, and launched to solve current bottlenecks in immunotherapy research and development.

Team

Associate Scientist

Alyssa Amezquita

Associate Scientist

Codian Powell, MS

SVP Engineering

Ian Walton

Director, Applications

Justin Madrigal, PhD

Director, Chemistry

Nathan Schoepp, PhD

Co-Founder & CEO

Russell Cole, PhD

Team

Advisors

Co-Founder

Adam Abate, PhD

Advisor & Investor

Bill Hyun, PhD

Scientific Advisor

Lawrence Fong, MD

Team

Advisor & Investor

Paul McEwan

Co-Founder

Zev Gartner, PhD

Careers

We are always interested in talented individuals who share our passion for accelerating therapeutic development. Please drop us a line at info@scribebiosciences.com.

Scribe Biosciences Wins CYTO 2022 Technology Showcase

Microenvironment On Demand technology was invented by key innovators at the University of California, San Francisco, and launched to solve current bottlenecks in immunotherapy research and development.

Team

Team

Advisors

Team

Careers

953 Indiana St.
San Francisco, CA 94107
Email: info@scribebiosciences.com